Skip to main content
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. — Investor Relations & Filings

Ticker · OVID ISIN · US6904691010 LEI · 549300H36NUI4L6U8F17 US Manufacturing
Open in API
Filings indexed 497 across all filing types
Latest filing 2022-05-02 Proxy Solicitation & In…
Country US United States of America
Listing US OVID

About Ovid Therapeutics Inc.

https://ovidrx.com/

Ovid Therapeutics Inc. is a biopharmaceutical company that develops targeted small molecule therapies for neurological conditions. The company's primary focus is on conquering epilepsies and other brain disorders by creating treatments that aim to reduce seizures and offer improved safety and tolerability. Ovid's scientific approach involves pioneering compounds with unique or potentially best-in-class mechanisms of action to address significant unmet medical needs. The company's mission is to develop medicines that improve the lives of patients and families affected by these conditions.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes details about the upcoming Annual Meeting of Stockholders, voting instructions, and proposals such as election of directors and ratification of the independent auditor. The document is titled 'Definitive Additional Materials' related to the proxy statement, indicating it is part of the proxy solicitation materials. This fits the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is 4174 characters, which is consistent with a proxy statement or related materials. Therefore, the correct classification is PSI with high confidence.
2022-05-02 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.